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Abstract
Background: The aim of this study was to establish precision-cut bovine udder slices (PCBUS) as an in-vitro-model
to investigate pathophysiological processes in the early phase of mastitis in order to have the possibility to
investigate new therapeutic approaches for the treatment of such udder inflammation in later studies. Furthermore,
this model should contribute to substitute in-vivo-experiments. Bovine mastitis is one of the most common and
costly infectious diseases in the dairy industry, which is largely associated with the use of antimicrobial agents.
Given this problem of antimicrobial resistance, it is essential to step up research into bacterial infectious diseases.
Thus, the transfer of the in-vitro-model of precision-cut tissue slices to the bovine udder enables broad research
into new therapeutic approaches in this area and can also be used to address issues in basic research or the
characterisation of complex pathophysiological processes.
Results: A stimulation with LPS, PGN or the combination of both substances (LPS:PGN) demonstrates the ability of
the PCBUS to react with a significant secretion of IL-1ß, TNF-α and PGE2.
Conclusion: The slices represent an instrument for investigating pharmacological interactions with udder tissue,
which can be useful for studies on pharmacological questions and the understanding of complex
pathophysiological processes of infection and inflammation.
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Background
In view of the threatening global problem of antibiotic
resistance, it is essential to intensify research on bacterial
infectious diseases [1]. It is important to examine
additional treatment options for infections caused by
bacteria to ensure the efficacy of antibacterial agents in
the future [2]. These options can offer new classes of
antimicrobials or other agents. Investments in the
development of new antibiotics have become more or
less commercially attractive for pharmaceutical industries
due to the increasing regulation and restriction of the use
of antibiotics [3].
The principle of the 3 Rs and the promotion of the
development and validation of alternatives to animal
testing are enshrined in the EU directive 2010/63/EU.
Various scientific approaches are already being used to
investigate research questions in physiology or patho-
physiology ranging from cell cultures on the one hand to
in-vivo-experiments on the other. Precision-cut tissue
models may serve as a bridge between cell culture and
in-vivo-experiments. Various working groups demon-
strated that precision-cut tissue slices can also successfully
be used for experimental studies [4–6]. Among them, the
model was applied to the lung or liver of various species,
which is the reason why it has now been attempted to
transfer the model to the bovine udder. In the cell associ-
ation, studies on physiological and pathophysiological
issues of the udder have so far been mainly carried out on
explant cultures, where the tissue to be cultured was
mostly obtained with scissors or a scalpel [7–9]. The size
of the individual explants varied [9, 10]. In one study,
udder tissue pieces of 2 mm3 were generated and
stimulated with LPS, LTA and S. aureus [9]. The
stimulation with LPS and S. aureus induced a signifi-
cant increase in cytokine reaction. Another working
group had the ability to show a possible stimulation on
teat explants. They were able to show pathogen- and
location-specific cytokine and chemokine reactions on
these explants [8].
The topic of this study was the investigation of the
suitability of precision-cut bovine udder slices (PCBUS)
as an in-vitro-model for investigations of the early
phase of bacterially caused inflammation. This should
provide an in-vitro-model that allows the investigation
of physiological as well as pathophysiological processes
in the udder. It can be used for the research of different
pharmacological agents and contribute to the develop-
ment of alternative, efficient therapeutic approaches to
minimize the use of antibiotics. In addition, the model
should reduce the number of necessary in-vivo-studies.
Results
Viability
To verify whether the cells of the udder tissue survived
the process of generating PCBUS, an MTT assay was
performed immediately after generating as well as every
24 h for as long as possible. Figure 1 shows the viability
of PCBUS in the first viability study over a period of 0 to
13 days of incubation. As negative control Triton X-100
treated PCBUS showed a significant diminished viability
until day 9. A limit of 70% of viability compared to time
0 (6 h after slaughter) was used as described in ISO
10993-5:2009 [11]. Derived from this, a period of 5 days
was set for the main experiments. Only PCBUS with a
viability of more than 70% compared with time 0 were
used for stimulation experiments.
Fig. 1 Viability of PCBUS over a period of 13 days; Triton X-100 represents the result of the negative control; the red dotted line symbolised a
viability limit of 70%; n.m.: not measured; data are given as mean + standard deviation of 7 PCBUS from 4 udders each
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Figure 2 shows the viability of the PCBUS which were
used for stimulation tests. It should be noted that all
PCBUS involved in the experiment had a viability of
more than 70% compared with time 0 up to the end of
the experiment.
Morphology
After PCBUS has been obtained, the morphology should
be examined to ensure that the structure of the cells is
not lost in this newly applied method. Figure 3 shows
the typical histology of bovine gland tissue (magnification
20 x). Several alveoli filled with protein residues can be
identified, which are separated from the lumen by epithe-
lial cells. Intralobular milk ducts run in the interstitial con-
nective tissue. The thickness of PCBUS deviated by ±15%
from the target value of 250 μm as shown in Fig. 4 (magni-
fication 20 x).
Cytokine secretion
To assess the possibility of stimulating cells from these
PCBUS, we investigated their ability to respond to
pro-inflammatory stimuli to which the mammary
gland epithelium is exposed during bovine mastitis.
We investigated cytokine levels in the supernatant of
the experimental approaches for IL-1ß, PGE2 and
TNF-α. Figure 5 shows the IL-1ß-release profile of
PCBUS after stimulation with LPS (1 μg/mL), PGN
(1 μg/mL) or a combination of both substances (1 μg/
mL each) over time. A significant increase after 1 h is
seen in PCBUS incubated with the combination of
the two stimulants, while no significant increase in
cytokine concentration can be seen after stimulation
of PCBUS with the other substances.
A time-related increase in PGE2-concentrations is
obvious in all stimulation approaches. Significant differ-
ences in PGE2-release was observed in PCBUS incubated
with LPS and the combination (LPS:PGN) shown in
Fig. 6.
A significant increase in TNF-α-release was detected
24 h after LPS-stimulation (Fig. 7).
Discussion
Aim of the study
Various scientific approaches were already been used to
investigate the physiology and pathophysiology of
inflammatory processes caused by infections as well as
pharmacological interventions, ranging from cell culture
experiments to in-vivo-studies [12–14]. A benefit of in-
vitro-studies is the possibility to use larger numbers of
replicates. This is rarely possible in ex-vivo- or in-vivo-
experiments due to higher costs, lack of tissue availabil-
ity and ethical issues [15]. It should be noted that there
are also significant individual differences between genet-
ically similar animals, requiring research on a large num-
ber of animals and consequently long and expensive
experimental set-ups, having a greater impact on animal
welfare [16]. Therefore, precision-cut tissue slices may
be helpful to perform experimental studies before animal
studies are performed. It was the aim of the present
study to establish PCBUS as a possible replacement and
complement to in-vivo-infection experiments.
Tissue sources and preparation
In the described study, bovine udders of slaughtered
dairy cows were used. In the past, it was demonstrated
in several studies that slaughter material can be used to
investigate different issues with reproducible results
[17–19]. Although the udders were already adspectively
and palpatorically examined on site and only the udders
found to be healthy were selected for transport to the
laboratory, in the laboratory additionally, the so-called
Fig. 2 Viability of PCBUS, which were used in the stimulation
experiment; Triton X-100 represents the result of the negative control;
the red dotted line symbolized a viability limit of 70%; data are given
as mean + standard deviation of 5 PCBUS from 6 udders each
Fig. 3 HE-staining of PCBUS shows physiological morphology of
bovine udder; arrow 1 points to an alveolus; arrow 2 points to the
interstitium; magnification 20 x
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California Mastitis Test (CMT) was performed with the
milk of the supposedly healthy udder. Only udders
whose cell count in the milk at the CMT was below
100.000 were included in the experiments. However,
these examinations did not reveal totally whether there
was a subclinical inflammation in the present organ. It
should be helpful to get information about the stage of
lactation of the slaughtered cows. Unfortunately, this
was not possible in the present study. Because no
preliminary report was available for the dissected udders,
this is a limitation of the model.
When cutting the udder tissue, it became apparent
that the udder quarters have a variable tissue structure
and consistency. This interesting discovery mostly corre-
lated with the size of the udder. In consequence, it was
always important to adapt the method of obtaining
PCBUS; the different lactation stages and the differences
for milk in the udder required an adjustment of the
Fig. 4 Histological section of a PCBUS (HE-staining); thickness measurement in μm; magnification 20 x
Fig. 5 IL-1ß cytokine release profile after stimulation of PCBUS with PGN, LPS and the combination of both substances; performed with 3 PCBUS
from 6 udders each; data are given as mean + standard deviation of 3 PCBUS from 6 udders each
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number of washing steps to remove the remaining milk
from the tissue. Based on the results of this feasibility
study, it is therefore recommended that udder health
(adspection, palpation, CMT result) and udder size (cow
age, lactation stage) must to be taken into account when
selecting the sample material. In future studies it is now
possible, for example, to investigate differences between
the individual lactation or age stages.
The measurement of the tissue slice thickness (Fig. 4)
confirmed a good reproducibility with regard to the
method of sample preparation. This shows the success
of the cutting technique using the dermatome, which is
important because tissue thickness can influence its cul-
tivability and nutrient supply. Previous studies showed
that precision-cut lung slices (PCLS) are better supplied
with oxygen and nutrients at a section thickness of
250 μm [20] than the precision-cut lung slices generated
with a thickness of 500–1000 μm [21].
An advantage of the described method is the gener-
ation of large number of PCBUS.
If the cutting and punching technique is correctly
applied, more than 200 precision-cut udder slices can be
obtained from one udder quarter. This allows simultan-
eous experimental approaches to the material and
thereby originate from only one animal. In comparison
to other studies, the technique used here has the advan-
tage that the thickness of the samples [9] and thus the
diffusion distance for nutrients and metabolites is
smaller, resulting in a better exchange between tissue
and environment, as already described for PCLS [20].
Fig. 6 PGE2 release profile after stimulation of PCBUS with PGN, LPS and the combination of both substances; data are given as mean + standard
deviation of 5 PCBUS from 6 udders each
Fig. 7 TNF-α cytokine release profile after stimulation of PCBUS with PGN, LPS and the combination of both substances; data are given as
mean + standard deviation of 5 PCBUS from 6 udders each
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Morphology
The histological examination of HE stained PCBUS
confirms the typical morphology of bovine udder tissue
(Fig. 3). This is consistent with results of previous
studies [9], also identifying the morphological struc-
ture of bovine udder tissue from their udder explants.
Our method not only allows the natural cell structure
to be preserved, sections can also be studied in histological
examinations, for example to check cell integrity after
external stimuli. In addition, maintaining a certain slice
thickness shows the high reproducibility of the model and
ensures that all PCBUS are equally supplied with culture
media.
Viability
The viability of the PCBUS were determined by the
MTT assay (Figs. 1 and 2). This test has already been
used in numerous studies and is one of the standard
tests for determining tissue or cell viability [22–24]. The
ISO 10993-5:2009 standard [11] describes, that MTT
assay results below 70% compared to 0 indicate reduced
viability. Consequently, this limit was used in this work
to exclude unsuited tissue slices. No PCBUS with via-
bility of less than 70% were used in the experiments.
However, it should be considered from which region of
the udder the samples are generated, as the tissue com-
position is variable (ratio of gland tissue and connective
tissue). Therefore, a sufficient number of PCBUS is
necessary to minimize deviations.
The metabolic conversion of the dye during the MTT
assay is done by the mitochondrial dehydrogenases of
the gland cells, in the connective tissue of PCBUS the
dye cannot be produced by corresponding cells. So, if
the ratio of glandular to connective tissue in the individ-
ual PCBUS is different, the result of this test could fluc-
tuate. However, the PCBUS obtained from one udder
showed for the most part a similar tissue structure, so
that a similar ratio of glandular to connective tissue is
assumed.
Nevertheless, the PCBUS could be reliably cultivated
and maintained in a viable condition for more than 96 h,
regardless of the tissue composition.
Early inflammatory reaction
LPS and PGN were used as stimulants for the experi-
ment, as these are cell wall components of Gram-
negative and Gram-positive bacteria, respectively,
which have an immunostimulating effect, thereby
recruiting immune cells and inducing the release of cy-
tokines [14, 25, 26]. The feasibility of the experimental
setup was confirmed by the fact that stimulation with
LPS or PGN was possible. The results of a stimulation
by LPS and PGN (1 μg/mL each) showed an enhanced
secretion of IL-1ß, TNF-α and PGE2 after stimulation.
After stimulation of PCBUS with LPS, a significant re-
lease of IL-1ß as well as PGE2 can be seen after only 1
h and is still visible after 4 and 6 h. In contrast to the
control, the release of PGE2 is even significant after 4
and 6 h. A combination of the two stimulants (LPS:
PGN) even led to a significant release of PGE2 after
only 1 h, until the end of the study period. In compari-
son, the release of IL-1ß was significant only after 1 h.
We also expected a significant increase in IL-1ß release
at the other measurement points in contrast to the
control. However, this could not be observed, which we
explained after the first investigations by the fact that
also the cells of the control PCBUS start to become
apoptotic and increase the IL-1ß concentration. This
requires further attention in future studies and needs to
be observed more closely. In contrast, a significant
release of TNF-α could only be shown after stimulation
with LPS 24 h. The stimulation of PCBUS with PGN
did not show a significant increase in any of the media-
tors, investigated at any time period considered. It must
of course be considered that cell types are confronted
with the stimulants that would not encounter the stim-
uli in vivo. In order to study cells that are only present
in the lumen or milk, a different model should be
chosen, e.g. the isolated perfused udder [18]. Therefore,
the PCBUS model focuses on the large time slot, which
allows longer-term examinations than the isolated per-
fused udder, where only studies of 8 h maximum are
possible.
It can be concluded, that the sections are useful to
study the effect of stimulating agents. Further investiga-
tions can provide information on how PCBUS react to a
bacterial infection.
Conclusion
Advantages of this method are the very high reproduci-
bility of the technique of obtaining tissue sections of
uniform size, kept viable over a large time slot for
stimulation and thus in the future also for infection
experiments. In addition, it is possible to preserve the
physiological cell structure and thus histological exami-
nations of the morphology in physiological and patho-
physiological stages. The differentiated immunological
response of PCBUS to different stimulants gives reasons
to hope that in the future the processes of bovine mas-
titis can be simulated in vitro and thus new therapeutic
options can be investigated. Thus, it is interesting for
future studies to investigate a larger gene spectrum of
innate immunity, e.g. with RT-qPCR or RNA sequence
analysis. Furthermore, there are some variations in our
collected data that can be explained by the procurement
of the sample material. Since the udders are obtained
from the slaughterhouse, we do not have any prelimin-
ary reports on the animals. Therefore, we do not know
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whether the animal suffered from subclinical mastitis at
the time of slaughter and what the immune status of the
animal was. In sum, the described methodology makes it
possible to generate precision-cut bovine udder slices
(PCBUS), may be used for experimental pharmacological
studies in the future.
Methods
Tissue sources and preparation
Before the preparation of precision-cut bovine udder
slices (PCBUS), udders of slaughtered cows (German
Holstein Friesian) were immediately examined for udder
health by adspection and palpation. The dissected udder
was infused by heparinized tyrode solution right away to
prevent clot formation in the vessels [18] and instantly
transported to the laboratory. In the laboratory, we
performed the so-called California Mastitis Test (CMT)
with the milk of the supposedly healthy udder. The
CMT is used to determine the cell count in the milk,
which is an additional indicator of udder health. A piece
of approximately 10 × 10 × 5 cm was cut out with a
sterile scalpel blade. A dermatome (Zimmer U.K. Ltd.,
Swindon, United Kingdom) was used to get tissue slices
with a thickness of 250 μm (see supplementary video 1,
Additional file 1). The obtained tissue slices were rapidly
washed in sterile phosphate-buffered saline (pH = 7.4;
PBS) until a clear solution without milk contamination
was achieved. Up to 200 PCBUS biopsy punches (6 mm
diameter) were than taken from the slices (Fig. 8), trans-
ferred to 24-well plates and washed with RPMI-1640
medium (Biochrom GmbH, Berlin, Germany), supple-
mented with 20% fetal calf serum (FCS; Biochrom GmbH),
10% penicillin streptomycin (10,000 international units
(I.U.)/mL/ 10,000 μg/mL, Biochrom GmbH), 10% ampho-
tericin B (PAA, Laboratories GmbH, Pasching, Austria) and
15 μg/mL gentamicin (PAA Laboratories GmbH) on an or-
bital shaker (130 rpm) in accordance to Magro et al. [9].
Two additional washing steps were performed with RPMI-
1640-medium, supplemented with 10% FCS, 1% penicillin
streptomycin, 1% amphotericin B and 15 μg/mL gentamicin
(maintenance medium). The slices were put into a new 24-
well plate (Greiner Bio-One, Frickenhausen, Germany) and
incubated in 1mL of maintenance medium in a humidified
atmosphere containing 5% CO2 at 37 °C. Incubation was
performed for 13 days totally and the medium was changed
every 48 h.
Viability of PCBUS
In first experiments with four udders, viability of the
PCBUS was tested from time point 0 h (6 h after slaugh-
tering) until day 13, whereby the medium was changed
every 48 h. For this purpose, the MTT assay was
performed daily with 7 PCBUS of the respective udder.
The MTT assay as described by Lambermont et al. [25]
was used with some modifications. The PCBUS were
transferred into a 24-well plate with 900 μL RPMI-1640-
medium and 100 μL 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyl tetrazolium bromide solution (MTT, 7 mg/mL;
Sigma-Aldrich, Steinheim, Germany). After 15 min of
incubation, the supernatant was discarded and 200 μL of
an intermixture (5% formic acid + 95% propanol; Sigma-
Aldrich) was added. After a further 40 min, 100 μL
supernatant were transferred to a 96-well plate (Greiner
Bio-One) for extinction measurement at 570 nm (MRX-
reader, Dynatech, Denkendorf, Germany). As negative
control, PCBUS were digested with Triton X-100 (Sigma-
Aldrich; 1 mL, 30min, 37 °C, 5% CO2 atmosphere) 30min
before starting the MTT assay. All steps were carried out
at room temperature in the dark. The main trials (stimula-
tion trials) were performed over a period of 5 days. There-
fore, 5 PCBUS of each of the 6 udders used in the trials
were checked daily by the MTT assay for their viability,
until the end of the experiments.
Fig. 8 a glandular tissue of the udder after using a dermatome with a layer thickness of 250 μm in a petri dish with sterile PBS; b glandular tissue
after punching; c obtained PCBUS with a diameter of 6 mm
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Stimulation of PCBUS with LPS and PGN
One day before stimulation, PCBUS were incubated in
RPMI-1640-medium, supplemented with 10% FCS, but
without any antibiotics, in a humidified atmosphere
containing 5% CO2 and 37 °C. To simulate a patho-
physiological reaction, initiated by bacterial toxins during
early phase of infection, 1 μg/mL lipopolysaccharide (LPS;
Sigma-Aldrich) of E. coli O55:B5, 1 μg/mL peptidoglycan
(PGN from S. aureus, Sigma-Aldrich) and a combination
of LPS and PGN was added to the incubation medium. As
a control, unstimulated PCBUS were used. These PCBUS
were incubated with RPMI-1640-medium, supplemented
with 10% FCS. One hour and two hours post stimulation,
30 μL supernatant and after 4 h, 6 h and 24 h, 130 μL
supernatant were sampled. After removal of the samples,
the wells were refilled with fresh medium (RPMI-1640-
medium + 10% FCS; without any stimulants). The experi-
ments were performed in triplicates from 6 different
udders.
Tissue slices sampled the same time points and were
used for histological examination from other wells.
A graphical representation of the experimental setup
and sample collection is shown in Figs. 9 and 10.
Measurement of IL-1ß, TNF-α and PGE2
Concentrations of IL-1ß, TNF-α and PGE2 in superna-
tants were measured with ELISA kits, according to the
manufacture’s specification (bovine Interleukin-1ß
Reagent Kit Invitrogen, Thermo Fisher Scientific;
Prostaglandin E2 Express ELISA Kit Cayman Chemical
Company, Ann Arbor, USA; Bovine TNF-alpha DuoSet®
ELISA DuoSet® ELISA Development Systems, R&D
Systems, Minneapolis, USA). Dilutions of the samples were
determined in preliminary tests. For the determination of
the IL-1ß- as well as PGE2-concentrations, the samples
were diluted 1:10 according to the manufacturer’s instruc-
tions. For the determination of the TNF-α content, the
samples were applied undiluted.
Histological examination
For histological examination, PCBUS were fixed in 10%
buffered formalin for 48 h and embedded in paraffin
wax, using standard techniques. Three micrometres
slices were stained with hematoxylin eosin staining (HE
staining). All sections were examined by light micros-
copy. The thickness of PCBUS were measured by using
computer-aided software (AxioVision Software).
Statistical analysis
The results are presented as mean ± standard deviation
(SD). The statistical evaluation was performed with
GraphPad Prism (Version 8.0.1, GraphPad Software,
Inc.). In the experiments, the results of the control
groups at the respective measurement time were
Fig. 9 Overview of the chronological course of the experiment
Fig. 10 Overview of sample collection at different time points
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compared with those of the stimulated group, with re-
gard to significant differences, using the Kruskal-Wallis
test. The significance of error probability of 5% was con-
sidered significant, with significances of ≤0.01 and ≤
0.001 being particularly marked in the figures.
Abbreviations
CMT: California mastitis test; E. coli: Escherichia coli; FCS: Fetal calf serum;
HE: Hematoxylin eosin; IL-1ß: Interleukin-1ß; LPS: Lipopolysaccharide;
LTA: Lipoteichoic Acid; MTT: 3-(4,5-dimethylthiazol-2-yl)-2,5-
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